The Evolution of Prescription Insurance: A Pharmacist’s Concern

Prescription insurance, once a beacon of hope for millions seeking affordable healthcare, has evolved dramatically over the years. As a pharmacist at Value Rx Pharmacy, I have witnessed firsthand how these changes have increasingly burdened patients, especially with the rising in cost of living of California, often putting their health and well-being at risk.

The Early Days: Promise and Potential

In the past, prescription insurance was designed to make medications more accessible and affordable. Patients paid modest copays, and insurance companies covered a significant portion of the costs. This system worked relatively well, ensuring that people could get the medications they needed without severe financial strain.

The Shift: Rising Costs and Complex Policies

Over the years, the landscape of prescription insurance has changed dramatically. Insurance companies have implemented more complex policies, higher copays, and significantly increased deductibles, making it harder for patients to afford their medications. Even though there are contracts for patients to read before they sign up for insurance, the complicated language ensures that nobody will read and understand it fully. According to a study by the Kaiser Family Foundation, the average deductible for employer-sponsored health plans has increased by 162% over the past decade. This rise in out-of-pocket costs has forced many patients to decide between life necessities and lifesaving medications.

The Burden of Deductibles

One of the most significant changes impacting patients is the dramatic increase in deductibles. A deductible is the amount a patient must pay out-of-pocket before their insurance coverage begins to pay. This shift towards higher deductibles is a strategy employed by insurance companies to lower premiums, but it places a substantial financial burden on patients. According to the Commonwealth Fund, in 2019, 43% of adults with employer-sponsored health plans had deductibles of $1,000 or more, compared to just 17% in 2007. For many, reaching this deductible is nearly impossible, particularly for those living paycheck to paycheck. Occasionally, we also see patients with astronomical deductibles that is in the $10,000s. Nobody can meet that amount of deductible if they do not have to use many medications.

The Burden of Formularies and Prior Authorization

Additionally, restrictive formularies and prior authorization requirements have further complicated access to medications. These practices are designed to control costs for insurance companies but often result in delays and denials of necessary medications for patients. A survey by the American Medical Association found that 91% of physicians reported that prior authorizations have delayed patient care, and 75% said they can lead to treatment abandonment. Your doctors should be the ones who know your medication therapy best, not an insurance company that makes decisions to cover your medications based on their profits. In some extreme cases, the delay in therapy can also lead to the loss of lives.

The Burden of Cost of Living Crisis in California

In California, the rising cost of living has compounded these issues, making it even harder for patients to afford their medications. The state’s high housing costs, coupled with increasing prices for basic necessities, have left many patients with little room in their budgets for healthcare expenses. According to the California Budget & Policy Center, nearly 20% of Californians live in poverty when adjusted for the cost of living. This economic strain forces many to prioritize other essentials over their medications, exacerbating health disparities and putting their well-being at risk.

The Unseen Consequences: Non-Adherence and Health Risks

The financial burden of prescription medications has led to a troubling trend: medication non-adherence. Patients are skipping doses, cutting pills in half, or abandoning treatments altogether because they simply cannot afford them. The American College of Cardiology reports that nearly 14% of patients with cardiovascular disease have skipped medications due to cost. This non-adherence not only worsens their conditions but also leads to increased healthcare costs in the long run due to hospitalizations and complications.

Real Story from Patients

At Value Rx Pharmacy, we encounter heartbreaking stories every day. Patients come to us, prescriptions in hand, only to find out that their insurance will not cover the medication until they meet their deductible, or the copay is prohibitively expensive. For instance, recently an elderly patient came into our pharmacy to fill a prescription for his scalp, ravaged by skin cancer. Despite having Medicare, his medication Clobetasol 0.05% solution – a potent topical corticosteroid needed to alleviate his severe inflammation – came with a staggering $58 copay. This man, retired and struggling on a fixed income, faced an agonizing choice: endure the unbearable symptoms or sacrifice essentials to afford his medication. This same medication can cost up to $155.13 at chain pharmacy. Even with a GoodRx coupon, the cost was still an unjust $28.56. With our Cost-Plus Pricing, we were able to offer him the medication for just $16.77, based on our cost of $8.50. He no longer had to choose between groceries and medication.

Putting Patient First

As a pharmacist serving in Orange County California, it is disheartening to see patients suffer due to the evolving prescription insurance landscape. At Value Rx Pharmacy, we thrive to mitigate these challenges by offering medication pricing that patients can afford and we do our very best to work with patients to find affordable alternatives.

A systemic change is needed to truly make a difference. Policymakers must prioritize patient needs over profits. This includes regulating drug prices, simplifying insurance policies, prior authorization and reimbursement to pharmacies. Only then can we return to a system where prescription insurance fulfills its original promise: ensuring that every patient has access to the medications they need without undue financial hardship.

References

  • 1. Kaiser Family Foundation. “2020 Employer Health Benefits Survey.” [Link](https://www.kff.org/health-costs/report/2020-employer-health-benefits-survey/).
  • 2. American Medical Association. “2019 AMA Prior Authorization Physician Survey.” [Link](https://www.ama-assn.org/system/files/2020-06/prior-authorization-survey-2019.pdf).
  • 3. American Diabetes Association. “Insulin Affordability and Access in the United States.” [Link](https://www.diabetes.org/advocacy/insulin-affordability).
  • 4. American College of Cardiology. “Impact of Medication Costs on Adherence in Cardiovascular Disease.” [Link](https://www.acc.org/latest-in-cardiology/articles/2018/09/20/12/42/impact-of-medication-costs-on-adherence-in-cardiovascular-disease).
  • 5. Commonwealth Fund. “The Growth in High-Deductible Health Plans.” [Link](https://www.commonwealthfund.org/publications/issue-briefs/2019/aug/growth-high-deductible-health-plans).
  • 6. California Budget & Policy Center. “Making Ends Meet: How Much Does It Cost to Support a Family in California?” [Link](https://calbudgetcenter.org/resources/making-ends-meet/).
Share the Post:

Related Posts